Estimated antiretroviral therapy coverage among children in SEAR
SEAR: Estimated antiretroviral therapy coverage among children was 11 in 2025. ◆ Volatile
Latest (2025)
11
Change on year
unchanged
Rank
7th
of 7 groups
All-time high
12
in 2018
All-time low
0
in 2000
Years of data
26
2000–2025
Estimated antiretroviral therapy coverage among children in SEAR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among children in SEAR is 11, measured in 2025.
The figure is up 10.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among children in SEAR peaked at 12 in 2018 and was at its lowest, 0, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among children in SEAR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 1 | — |
| 2002 | 1 | +0.0% |
| 2003 | 2 | +100.0% |
| 2004 | 2 | +0.0% |
| 2005 | 3 | +50.0% |
| 2006 | 3 | +0.0% |
| 2007 | 4 | +33.3% |
| 2008 | 4 | +0.0% |
| 2009 | 5 | +25.0% |
| 2010 | 6 | +20.0% |
| 2011 | 6 | +0.0% |
| 2012 | 7 | +16.7% |
| 2013 | 8 | +14.3% |
| 2014 | 9 | +12.5% |
| 2015 | 10 | +11.1% |
| 2016 | 11 | +10.0% |
| 2017 | 11 | +0.0% |
| 2018 | 12 | +9.1% |
| 2019 | 12 | +0.0% |
| 2020 | 12 | +0.0% |
| 2021 | 11 | -8.3% |
| 2022 | 11 | +0.0% |
| 2023 | 11 | +0.0% |
| 2024 | 11 | +0.0% |
| 2025 | 11 | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.5 | 0 | 5 | 10 |
| 2010s | 9.2 | 6 | 12 | 10 |
| 2020s | 11.17 | 11 | 12 | 6 |
Countries ranked near SEAR
- 6 Botswana 82 compare
- 7 Mali 77 compare
- 8 Thailand 76 compare
- 8 Kazakhstan 76 compare
- 8 Netherlands 76 compare
More health data for SEAR
- Mortality rate among children ages 5 to 9 years 1.94 (2024)
- Population with primary reliance on polluting fuels and technologies 493.79 (2023)
- Prevalence of diabetes, crude 20.36 (2022)
- Population with primary reliance on fuels and technologies for 470.67 (2023)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 96.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 96.0% (2025)
- New HIV infections 0.1 (2025)
- Stunting prevalence among children under 5 years of age (%) 29.7% (2024)
- Mean total cholesterol, crude 4.3 (2018)
- Adolescent mortality rate 2.27 (2021)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among children in SEAR?
- Estimated antiretroviral therapy coverage among children in SEAR was 11 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among children recorded in SEAR?
- The highest recorded value was 12 in 2018.
- What is the lowest estimated antiretroviral therapy coverage among children recorded in SEAR?
- The lowest recorded value was 0 in 2000.
- How does SEAR rank for estimated antiretroviral therapy coverage among children?
- SEAR ranks 7th out of 7 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among children rising or falling in SEAR?
- Over the last ten years it is up 10.0%. The long-run trend across the full record is volatile.
- Where does this SEAR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among children. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).